文献速递乳房整形与再造

自体与植入物乳房再造的自付费用与支付:一项全国性分析

Out-of-Pocket Costs and Payments in Autologous and Implant-Based Breast Reconstruction: A Nationwide Analysis.
PubMed 文献 · Ann Plast Surg · 2024-01-01

基于IBM MarketScan商业数据库2017至2021年数据,纳入2079例自体乳房再造和1475例植入物乳房再造住院病例。自体再造的中位自付费用(597美元 vs 250美元,P<0.001)和中位总支付(63667美元 vs 31472美元,P<0.001)均显著高于植入物再造。回归分析显示自体再造显著增加自付费用(B=597美元,P=0.025)和总费用(B=74507美元,P=0.006)。

要点

  • 自体乳房再造中位自付费用597美元,显著高于植入物再造的250美元(P<0.001)。
  • 自体乳房再造中位总支付63667美元,显著高于植入物再造的31472美元(P<0.001)。
  • 保险计划类型和地区与自付费用差异相关(P<0.001)。

核心结论

  • 美国全国数据显示,自体乳房再造的自付费用和总支付均高于植入物乳房再造。
  • 作者认为需要更多研究来确定这些财务差异在多大程度上影响患者决策。

研究设计与样本

  • 查询IBM MarketScan商业数据库,提取2017年至2021年所有接受住院自体或植入物乳房再造的患者。
  • 样本包括2079例自体乳房再造和1475例植入物乳房再造病例。
  • 采用单变量回归评估自体与植入物再造手术之间的差异,并使用混合效应线性回归分析对总支付和自付费用的参数贡献。

主要发现

  • 自体再造的中位自付费用为597美元,植入物再造为250美元(P<0.001)。
  • 自体再造的中位总支付为63667美元,植入物再造为31472美元(P<0.001)。
  • 保险计划类型和地区与自付费用变异相关(P<0.001)。
  • 回归分析显示自体再造显著增加自付费用(B=597美元,P=0.025)和总费用(B=74507美元,P=0.006)。

关键数值与推荐

  • 自体乳房再造中位自付费用597美元 vs 植入物乳房再造250美元(P<0.001)。
  • 自体乳房再造中位总支付63667美元 vs 植入物乳房再造31472美元(P<0.001)。
  • 自体再造对自付费用的回归系数B=597美元(P=0.025),对总费用的回归系数B=74507美元(P=0.006)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者认为需要更多研究来确定这些财务差异在多大程度上影响患者决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Many factors influence a patient's decision to undergo autologous versus implant-based breast reconstruction, including medical, social, and financial considerations. This study aims to investigate differences in out-of-pocket and total spending for patients undergoing autologous and implant-based breast reconstruction. METHODS: The IBM MarketScan Commercial Databases were queried to extract all patients who underwent inpatient autologous or implant-based breast reconstruction from 2017 to 2021. Financial variables included gross payments to the provider (facility and/or physician) and out-of-pocket costs (total of coinsurance, deductible, and copayments). Univariate regressions assessed differences between autologous and implant-based reconstruction procedures. Mixed-effects linear regression was used to analyze parametric contributions to total gross and out-of-pocket costs. RESULTS: The sample identified 2079 autologous breast reconstruction and 1475 implant-based breast reconstruction episodes. Median out-of-pocket costs were significantly higher for autologous reconstruction than implant-based reconstruction ($597 vs $250, P < 0.001) as were total payments ($63,667 vs $31,472, P < 0.001). Type of insurance plan and region contributed to variable out-of-pocket costs (P < 0.001). Regression analysis revealed that autologous reconstruction contributes significantly to increasing out-of-pocket costs (B = $597, P = 0.025) and increasing total costs (B = $74,507, P = 0.006). CONCLUSION: The US national data demonstrate that autologous breast reconstruction has higher out-of-pocket costs and higher gross payments than implant-based reconstruction. More study is needed to determine the extent to which these financial differences affect patient decision-making.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Oleru OO, Seyidova N, Taub PJ, et al. Out-of-Pocket Costs and Payments in Autologous and Implant-Based Breast Reconstruction: A Nationwide Analysis. Ann Plast Surg. 2024. PMID: 38556686. doi:10.1097/SAP.0000000000003864

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。